β¨ Medicines Consent Notices
NEW ZEALAND GAZETTE
No. 154
3950
Product:
Lemsip Max Day & Night
Daytime component:
Active Ingredients:
Dextromethorphan hydrobromide 10mg
Paracetamol 300mg
Pseudoephedrine hydrochloride 30mg
Dosage Form:
Liquid filled capsule
Night-time component:
Active Ingredients:
Chlorpheniramine maleate 2mg
Paracetamol 300mg
Pseudoephedrine hydrochloride 30mg
Dosage Form:
Liquid filled capsule
New Zealand Sponsor:
Reckitt Benckiser (New Zealand) Limited
Manufacturer:
R P Scherer Holdings Pty Limited, Braeside, Victoria, Australia
Product:
X-Opaque HD
Active Ingredient:
Barium sulphate 966mg/g
Dosage Form:
Oral suspension
New Zealand Sponsor:
Siemens (NZ) Limited
Manufacturer:
Hellay Laboratories Pty Limited, Dandenong, Victoria, Australia
Dated this 9th day of October 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go6946
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product:
Serecid
Active Ingredient:
Hydroxyzine hydrochloride 10mg
Dosage Form:
Capsule
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Banner Pharmacaps (Canada) Limited, Olds, Alberta, Canada
Note: This consent is valid for two years from 26 November 2002.
Product:
Serecid
Active Ingredient:
Hydroxyzine hydrochloride 25mg
Dosage Form:
Capsule
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Banner Pharmacaps (Canada) Limited, Olds, Alberta, Canada
Note: This consent is valid for two years from 26 November 2002.
Dated this 9th day of October 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go6948
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Caelyx
Active Ingredient:
Doxorubicin hydrochloride 2mg/mL
Dosage Form:
Concentrate for infusion
New Zealand Sponsor:
Schering-Plough Pty Ltd
Manufacturer:
Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Product:
Cancidas
Active Ingredient:
Caspofungin acetate 57.8mg equivalent to 50mg caspofungin anhydrous free base
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturer:
Merck & Co Inc, West Point, Pennsylvania, United States of America
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 154
Gazette.govt.nz —
NZ Gazette 2002, No 154
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare9 October 2002
Medicines Act, New Medicines, Lemsip Max Day & Night, X-Opaque HD
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Renewal of Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare9 October 2002
Medicines Act, Provisional Consent, Serecid, Hydroxyzine hydrochloride
- G. R. Boyd, Chief Advisor, Safety and Regulation
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare9 October 2002
Medicines Act, Changed Medicines, Caelyx, Cancidas
- G. R. Boyd, Chief Advisor, Safety and Regulation